AM3, a natural glycoconjugate, as adjuvant treatment for COVID-19 patients
D. GÓMEZ-GARRE (Madrid, Spain), A. Ortega-Hernández (Madrid, Spain), J. Modrego (Madrid, Spain), R. Gómez-Gordo (Madrid, Spain), L. Espino (Madrid, Spain), N. Martell (Madrid, Spain), A. Corbatón (Madrid, Spain)
Source: International Congress 2022 – COVID treatments
Session: COVID treatments
Session type: Thematic Poster
Number: 2602
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. GÓMEZ-GARRE (Madrid, Spain), A. Ortega-Hernández (Madrid, Spain), J. Modrego (Madrid, Spain), R. Gómez-Gordo (Madrid, Spain), L. Espino (Madrid, Spain), N. Martell (Madrid, Spain), A. Corbatón (Madrid, Spain). AM3, a natural glycoconjugate, as adjuvant treatment for COVID-19 patients. 2602
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|